BMP Sunstone to Distribute Pfizer’s Endometriosis Treatment in China
publication date: Nov 10, 2009
BMP Sunstone Corporation (美国美华太阳石集团公司) and Pfizer China have formed a strategic partnership to distribute and promote Depo-Provera (Medroxy-progesterone Acetate), a Pfizer product used to treat endometriosis, in China. Endometriosis is a medical condition in women of childbearing age that can cause significant pain. Financial details of the agreement were not disclosed. More details...
Stock Symbols: (NSDQ: BJGP) (NYSE: PFE)
Sorry... this feature or article is only available to subscribers.